Format

Send to

Choose Destination
Pediatr Infect Dis J. 2010 Apr;29(4):376-9. doi: 10.1097/INF.0b013e3181c81fd4.

Antiretroviral-related hematologic short-term toxicity in healthy infants: implications of the new neonatal 4-week zidovudine regimen.

Author information

1
Department of Pediatrics, Pediatric Infectious Diseases Unit, Hospital Sant Joan de Déu-Universitat de Barcelona, Barcelona, Spain.

Abstract

Recent updates of the guidelines on the prevention of human immunodeficiency virus mother-to-child transmission have shortened the neonatal zidovudine prophylactic regimens from 6 to 4 weeks. We present a prospective observational study in a large cohort of mother-infant pairs and report that the 4-week regimen allows an earlier recovery of the anemia in these otherwise healthy infants.

PMID:
19949355
DOI:
10.1097/INF.0b013e3181c81fd4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center